China's large-scale COVID-19 testing may pave way for strong economic recovery, U.S. economist says

[onebyone]

A staff member collects sample for testing at Tongji community in Shulan, northeast China's Jilin Province, May 17, 2020. (Xinhua/Zhang Nan)

"Because China's economic recovery will depend largely on reviving its service sector, its strategy of large-scale testing for COVID-19 can help restore consumer confidence, paving the way for a stronger recovery in private consumption," Lardy said.

WASHINGTON, May 21 (Xinhua) -- China's large-scale COVID-19 testing may pave the way for a strong economic recovery, a renowned U.S. economist has said.

"Although there are no official national data on the number of tests that have been carried out in China, press reports suggest that China, at least in certain localities, has tested widely and strategically for COVID-19," Nicholas Lardy, senior fellow at the Washington D.C.-based think tank Peterson Institute for International Economics, wrote Tuesday in an analysis.

"Because China's economic recovery will depend largely on reviving its service sector, its strategy of large-scale testing for COVID-19 can help restore consumer confidence, paving the way for a stronger recovery in private consumption," Lardy said.

"Confidence generated by widespread testing that shows that the number of asymptomatic cases is quite limited is also a precondition for citizens to resume traveling, shopping, dining out, and so forth-all essential for the hard-hit service sector to recover," Lardy added.

A screenshot taken from the website of the Washington D.C.-based think tank Peterson Institute for International Economics on May 21, 2020, shows the picture and title of the article written by its senior fellow Nicholas Lardy, which says that China's large-scale COVID-19 testing may pave the way for a strong economic recovery. (Xinhua)

Widespread testing is also critical for avoiding a second wave of infections, which would lead to renewed lockdowns with their associated economic costs, noted Lardy.

Amid the COVID-19 impact, China's gross domestic product in the first quarter shrank 6.8 percent year on year, according to data released by China's National Bureau of Statistics.

Output in China will recover significantly in the second quarter and for the rest of the year, Jeffrey Sachs, a renowned economics professor at Columbia University and a senior United Nations advisor, told Xinhua recently.

"China's economic recovery will ultimately depend on the success of a large part of the world overcoming the epidemic in a cohesive manner," Sachs said. ■

http://www.xinhuanet.com/english/2020-05/21/c_139075761.htm

 

[onebyone]

https://twitter.com/x/status/1263494813728423936

 

[xuxu1457]

As of May 11, Guangdong Province had tested 10.41 million people.

 

[litman]

amazing feat by china.

 

[Menthol]

As of May 11, Guangdong Province had tested 10.41 million people.

Seriously???

That is quite stunning!

From where you get the data?

Is there any more data for other provinces?

 

[xuxu1457]

Seriously???

That is quite stunning!

From where you get the data?

Is there any more data for other provinces?

http://news.ifeng.com/c/7wdb2gB2tgw
Most parts of China have opened up nucleic acid testing at their own expense.Call 愿检尽检， If you want, you can go to the test, Guangdong Province, the price is about 150 yuan, 20 U. S. dollars, medical Insurance cover.

In addition to going to the hospital, 394 additional nucleic acid testing points have been opened, and online booking, testing and online inquiry results can be made.

From the news conference held by the Guangdong Provincial Health and Health Commission on May 14
http://wsjkw.gd.gov.cn/zwyw_xwfbh/content/post_2994180.html

Not including antibodies and other types of testing, only the most accurate nucleic acid testing, Guangdong Province has tested 6.79 million people, the previous report was 5.11 has tested 10.41 million copies.Some people in the quarantine or front-line work, need to be tested once after a period of time, a person will test many times

截至5月13日，全省累计开展核酸检测679万人，检测率为6.2%。全省核酸检测机构总体布局从最初的92家医疗机构、37家疾控机构、6家第三方检测机构扩容至170家医疗机构、53家疾控机构、28家第三方检测机构。在常态化防控下，我省将继续加强二级以上医疗机构、县区级以上疾控机构实验室建设，鼓励有资质的第三方检测机构提供检测服务，充分满足“愿检尽检”需求。近期，全省将以市为单位向社会公开检测机构信息，方便公众查询和预约核酸检测。
translation:As of May 13, a total of 6.79 million people had carried out nucleic acid tests in the Guangdong province, with a detection rate of 6.2%. The overall layout of nucleic acid testing institutions in the province has expanded from 92 medical institutions, 37 disease control institutions and 6 third-party testing institutions to 170 medical institutions, 53 disease control institutions and 28 third-party testing institutions. Under the normal prevention and control, our province will continue to strengthen the laboratory construction of medical institutions at or above the secondary level and disease control institutions at or above the county and district levels, encourage qualified third-party testing institutions to provide testing services, and fully meet the needs of "willing to inspect and complete inspection". In the near future, the province will open the information of testing institutions to the public in the city as a unit, so as to facilitate public inquiries and appointments for nucleic acid testing.

https://defence.pk/pdf/threads/coronavirus-in-china-updates-discussion.666778/
and
http://www.xinhuanet.com/english/2020-05/16/c_139062353.htm
China can conduct 1.5 mln COVID-19 nucleic acid tests a day: health official
Source: Xinhua| 2020-05-16 20:27:03|Editor: huaxia
BEIJING, May 16 (Xinhua) -- China is able to conduct 1.5 million nucleic acid tests for COVID-19 every day. Testing capabilities need to be further improved as work and production resume, said a Chinese health official Saturday at a press conference in Beijing.

The National Health Commission has called on all qualified and registered medical institutions across the country to conduct nucleic acid testing since the end of January to deal with the rapid growth of COVID-19 cases, said Guo Yanhong, an official with the commission.

The next step is to step up the building and management of laboratories, biosafety management and the training of medical personnel, said Guo. Enditem